1. Trang chủ
  2. » Luận Văn - Báo Cáo

Báo cáo khoa học: Structural and mutational analyses of protein–protein interactions between transthyretin and retinol-binding protein doc

14 267 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 14
Dung lượng 0,92 MB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

Remarkably, some of the residues in mutated human transthyretin that weaken or abolish the interaction with retinol-binding protein are present in piscine transthyretin, consistent with

Trang 1

interactions between transthyretin and retinol-binding

protein

Giuseppe Zanotti1,2, Claudia Folli3, Laura Cendron1,2, Beatrice Alfieri3, Sonia K Nishida4,

Francesca Gliubich1,*, Nicola Pasquato1, Alessandro Negro5and Rodolfo Berni3

1 Department of Chemical Sciences and Institute of Biomolecular Chemistry-CNR, University of Padua, Italy

2 Venetian Institute of Molecular Medicine, Padua, Italy

3 Department of Biochemistry and Molecular Biology, University of Parma, Italy

4 Department of Medicine, Federal University of Sa˜o Paulo, Brazil

5 Department of Experimental Veterinary Sciences and CRIBI, University of Padua, Italy

Keywords

Fab; mutational analysis; protein–protein

interactions; retinol-binding protein;

transthyretin

Correspondence

G Zanotti, Department of Chemical

Sciences, University of Padua, Via Marzolo

1, 35131 Padua, Italy

Fax: +39 049 8275239

Tel: +39 049 8275245

E-mail: giuseppe.zanotti@unipd.it

R Berni, Department of Biochemistry and

Molecular Biology, University of Parma, V.le

G.P Usberti 23 ⁄ A, 43100 Parma, Italy

Fax: +39 0521 905151

Tel: +39 0521 905645

E-mail: rodolfo.berni@unipr.it

*Present address

KCL Enterprises Ltd, London, UK

Database

Atomic coordinates and structure factors

have been deposited at the Protein Data

Bank (PDB) (http://www.rcsb.org) for

imme-diate release: PDB 3BSZ for the TTR–RBP–

Fab complex and PDB 3BT0 and 3CXF

for the V20S and Y114H TTR variants,

respectively

(Received 23 July 2008, revised

22 September 2008, accepted 25

September 2008)

doi:10.1111/j.1742-4658.2008.06705.x

Transthyretin is a tetrameric binding protein involved in the transport of thyroid hormones and in the cotransport of retinol by forming a complex

in plasma with retinol-binding protein In the present study, we report the crystal structure of a macromolecular complex, in which human transthy-retin, human holo-retinol-binding protein and a murine anti-retinol-binding protein Fab are assembled according to a 1 : 2 : 2 stoichiometry The main interactions, both polar and apolar, between retinol-binding protein and transthyretin involve the retinol hydroxyl group and a limited number of solvent exposed residues The relevance of transthyretin residues in com-plex formation with retinol-binding protein has been examined by muta-tional analysis, and the structural consequences of some transthyretin point mutations affecting protein–protein recognition have been investigated Despite a few exceptions, in general, the substitution of a hydrophilic for a hydrophobic side chain in contact regions results in a decrease or even a loss of binding affinity, thus revealing the importance of interfacial hydro-phobic interactions and a high degree of complementarity between retinol-binding protein and transthyretin The effect is particularly evident when the mutation affects an interacting residue present in two distinct subunits

of transthyretin participating simultaneously in two interactions with a reti-nol-binding protein molecule This is the case of the amyloidogenic I84S replacement, which abolishes the interaction with retinol-binding protein and is associated with an altered retinol-binding protein plasma transport

in carriers of this mutation Remarkably, some of the residues in mutated human transthyretin that weaken or abolish the interaction with retinol-binding protein are present in piscine transthyretin, consistent with the lack

of interaction between retinol-binding protein and transthyretin in fish

Abbreviations

PDB, Protein Data Bank; RBP, retinol-binding protein; TTR, transthyretin.

Trang 2

Transthyretin (TTR), a homotetramer of

approxi-mately 55 kDa, is a thyroid hormone-binding protein

present in the extracellular fluids of vertebrates,

where it participates, together with other binding

proteins, in the distribution of thyroid hormones

(thyroxine and triiodothyronine) [1] It was generated

during early vertebrate evolution as a result of a

duplication event in the gene encoding

5-hydroxyiso-urate hydrolase, an enzyme distributed in several

prokaryotes and in several eukaryotic lineages and

involved in purine metabolism [2–6] The

extracellu-lar transport of retinol (vitamin A alcohol) is

specifi-cally mediated by retinol-binding protein (RBP, also

known as RBP 4), a monomeric protein of 21 kDa

that delivers the vitamin molecule to the target cells

[7,8], where a membrane RBP receptor represents a

major mediator of cellular vitamin A uptake [9,10]

TTR and RBP are synthesized primarily by the

hepatocytes and are secreted into the circulation,

where RBP is found bound to TTR The association

of RBP with TTR increases the stability of the

reti-nol–RBP complex [11,12] and, according to various

lines of evidence [13–15], is believed to reduce the

glomerular filtration of the relatively small RBP

mol-ecule In turn, the stability of the RBP–TTR

com-plex is strongly affected by the presence of retinol

bound to RBP within the complex, a feature that is

believed to be of physiological significance The

affinity of holoRBP for TTR is significantly higher

than that of apoRBP [16,17], which is consistent

with holoRBP being retained in the circulation as

the protein–protein complex and with the

uncom-plexed apoRBP molecule, resulting from the delivery

of retinol, being selectively cleared from the

circula-tion by glomerular filtracircula-tion TTR has been

associ-ated with human diseases It is one of several

proteins that can produce the extracellular

accumula-tion in tissues of protein aggregates, in the form of

fibrils, which are responsible for degenerative diseases

known as amyloidoses; to date, more than 100 point

mutations have been described for TTR, most of

which are involved in familial amyloidoses [18,19]

Moreover, a protective role of TTR in Alzheimer’s

disease has recently been proposed [20,21] RBP is

an adipocyte-derived ‘signal’ that may contribute to

the pathogenesis of insulin resistance [22]

Well-refined crystal structures of TTR from

differ-ent vertebrate species, including mammals [23–25],

chicken [26] and fish (sea bream) [27,28], and of

RBP from mammals [29–33] and chicken [34], have

been described The crystal structures of heterologous

(human TTR–chicken RBP) [35] and homologous

(human TTR–human RBP) [36] TTR–holoRBP

com-plexes have also been determined, both characterized

by a 1 : 2 TTR : RBP stoichiometry in which each TTR-bound RBP molecule interacts simultaneously with three TTR subunits [35,36] TTR is a tetrameric protein formed by the assembly of four identical sub-units Each monomer is composed of eight anti-par-allel b-strands (A–H), arranged in a topology similar

to the Greek key b-barrel, with a short a-helix located at the end of b-strand E In the tetramer, the four monomers are organized as a dimer of dimers Specifically, two monomers are held together

to form a stable dimer through a net of H-bond interactions involving the two edge b-strands H and

F To form the tetramer, two dimers associate back

to back, mainly through hydrophobic contacts between residues of the loops formed by b-strands A and B and b-strands G and H One of the two-fold symmetry axes of the tetramer is coincident with a long channel that transverses the entire molecule and harbors two binding sites for thyroid hormones RBP is a single domain protein, made up of an N-terminal coil, eight anti-parallel b-strands (A–H) and a short a-helix close to the C-terminus The core of the protein is the internal cavity of an eight-stranded up-and-down b-barrel The vitamin mole-cule is accommodated within the cavity of the barrel: the b-ionone ring is innermost, the polyene chain is fully extended and the hydroxyl end group is almost solvent exposed, in the region of the loops that con-nect b-strands A and B, C and D and E and F and surround the entrance of the b-barrel at the open end of the cavity As a result of evolutionary restraints imposed by the multiple interactions estab-lished by both RBP and TTR, a high degree of structural similarity appears to be preserved for these two proteins from phylogenetically distant vertebrate species It should be noted, however, that piscine TTR and RBP lack the ability to form a protein– protein complex [27] The molecular basis of the evolution of the two piscine proteins into proteins that possess the ability to interact with each other in terrestrial vertebrates remains to be clarified

In the present study, we report on the structure of

a complex formed by the association of human TTR, human holoRBP and a murine anti-RBP Fab, and

on a mutational analysis of the RBP-binding determi-nants present in the human TTR molecule The data provide insight into the molecular basis of the altered plasma transport of RBP in carriers of a relevant amyloidogenic TTR mutation (I84S) and of the changes in the TTR molecule that have affected its ability to interact with RBP during the course of vertebrate evolution

Trang 3

Structure of a complex between human TTR,

human holoRBP and an anti-RBP Fab

The crystal structure of the human TTR–RBP

com-plex bound to an anti-RBP Fab could be determined

at a resolution of 3.36 A˚, similar to that obtained for

the crystal structures of TTR–RBP complexes [35,36]

The molecular model, obtained by molecular

replace-ment starting from the available high resolution

crys-tal structures of RBP and TTR, is of reasonable

quality The anti-RBP Fab is bound to an RBP

epi-tope that is well separated from the TTR-binding

determinants present in the RBP molecule It

inter-acts with RBP on the side opposite to that involved

in the binding to TTR (Fig 1A), so that the

interac-tions between RBP and TTR are not affected by the

RBP-bound Fab The entire complex, composed of

one TTR tetramer and two holoRBP molecules in

complex with Fab, is present in the asymmetric unit

(Fig 1A) The two RBP–Fab sub-complexes are

arranged symmetrically around the two-fold axis of

TTR running through the central channel that

trans-verses the TTR molecule RBP and TTR

substan-tially maintain the structure they have in the

uncomplexed state, with only minor changes in

con-tact regions

The region of entrance of retinol into the b-barrel

cavity of RBP (i.e loops 32–36, 63–67 and 92–98),

and retinol itself, participate in the recognition of

TTR, involving residues that are essentially located in

loops connecting b-strands of the tetrameric protein,

in such a way that one RBP molecule interacts

simul-taneously with three TTR subunits (Table 1 and

Fig 1A,B) The RBP–TTR interactions are both

polar or apolar (Table 1) The contact surface of

TTR is characterized by a prevalence of hydrophobic

residues in the case of the subunits B and C and of

hydrophilic residues in the case of the subunit A

Val20, Trp79, Leu82, Ile84, Pro113 and Tyr114 from

both subunits B and C of TTR form a hydrophobic

patch, which is in contact in the protein–protein

com-plex with the hydrophobic patch formed by the

resi-dues Trp67, Leu63, Leu64, Val69, Phe96 and Leu97

of RBP Instead, the interacting hydrophilic residues

from the subunit A of TTR are closer to the border

of the contact surface of TTR Four H-bonds, mainly

between RBP and the subunit B of TTR, are also

present (Table 1) The area buried on the two

pro-teins upon complex formation is 1443 A˚2, out of a

total area of 9307 and 21502 A˚2 for the two

sepa-rated RBP and TTR molecules, respectively

The Fab–RBP interaction involves the region pre-ceding the a-helix and the C-terminal b-strand of RBP and the hyper-variable regions of Fab: loops 53–56 and 100–103 and the short helix 28–32 of chain H and loops 31–36 and 53–56 of chain L The interactions, which are mainly polar and comprise several H-bonds, are summarized in Table 2 The number of residues involved in the formation of the Fab–RBP complex is smaller than that of interacting residues in the RBP– TTR complex (Table 2) but the surface buried upon complex formation is comparable to that for the RBP– TTR complex (1588 A˚2) The contacts between inter-acting surfaces of RBP and Fab are shown in Fig 1C

Mutational analysis of the RBP-binding determinants of TTR

The amino acid sequences of RBP and TTR from dif-ferent vertebrate species showing the residues of human RBP and TTR that are mainly involved in interactions, according to our structure of the TTR– RBP–Fab complex, are shown in Fig 2 The func-tional and structural consequences of several TTR point mutations on the RBP–TTR interactions have been investigated The values of the dissociation con-stants for several complexes between human TTR vari-ants and human RBP, as determined by means of fluorescence anisotropy titrations (Fig 3A), are reported in Table 3 For some TTR mutations that abolish or weaken significantly the RBP–TTR interac-tions, the crystal structures of the variants have been determined or already available structures have been examined to provide details of the interference with protein–protein recognition by mutations

V20S TTR variant Two Val20 residues present in two distinct TTR sub-units (B and C, according to our designation of TTR subunits) are located at the center of a large hydropho-bic patch in the contact area between TTR and RBP,

so that their replacement by a hydrophilic residue is expected to significantly impair protein–protein inter-actions Accordingly, the V20S mutation has been found to almost abolish the binding affinity between RBP and TTR (Table 3 and Fig 3A) To investigate the structural consequences of the V20S replacement

on the RBP–TTR recognition, we have determined the 1.6 A˚ resolution crystal structure of the V20S TTR variant The overall structure is very similar to that of the wild-type protein (PDB: 1F41) [25]: a superposition

of equivalent Ca atoms gives an rmsd of 0.40 and 0.68 A˚ for subunits A and B, respectively However,

Trang 4

B

C

Fig 1 Structure of the TTR–RBP–Fab complex (A) Representation of the overall structure of the TTR–RBP–Fab complex TTR: chain A, red; chain B, green; chain C, magenta; chain D, orange RBP: chains E and F, yellow Fab: heavy chains H and N, cyan; light chains L and M, blue (B) Detail of the contact between the TTR subunits A, B and C and the RBP molecule E [left side, color codes as in (A)] Center and right drawings show the interacting surfaces of RBP (center) and of the TTR subunits A, B and C (right) rotated by approxi-mately 90 counterclockwise and clockwise, respectively, compared to the previous view It is possible to appreciate how a protuberance formed by loops 63–67 and 92–98 on the RBP surface fits into a crevice formed by the arrangement of three TTR subunits (C) Detail of the contact between the RBP molecule F and the Fab chains H and L [left side, color codes as in (A)] Center and right drawings show the interacting surfaces of RBP (center) and Fab (right), rotated through a vertical axis by approximately 90 counterclockwise and clock-wise, respectively, compared to the previous view Residues 163–169 and the region preceding the a-helix contribute to the formation of the RBP epitope.

Trang 5

significant differences are observed for loop region

98–103, which connects b-strands G to F and is

flexi-ble in most TTR structures, and for loop 19–22, which

connects b-strands A and B and hosts the mutation

The movement of the latter loop is not large (the Ca

atom of Val20 is displaced by 1.6 A˚ from its position

in the wild-type structure) but the entire loop 19–22 is

displaced by more than 1.5 A˚ from its original position

(Fig 3B), so that the change in the positions of Val20

and Arg21 of two distinct TTR subunits (Table 1) may

interfere simultaneously with two interactions

estab-lished with RBP

I84S and I84A TTR variants

A drastic effect on the recognition between TTR and RBP is caused by mutations at position 84 The in vitro binding of the I84S and I84A TTR variants to RBP is abolished or becomes almost negligible, respectively [37] (Table 3 and Fig 3A) Accordingly, the lack of interaction between RBP and the amyloidogenic I84S TTR is known to lead to a markedly lowered plasma concentrations of RBP in individuals carrying the mutation due to the impaired transport function of the TTR variant [38] The explanation for this effect is not straightforward because the structures of the I84S (PDB: 2G4G) [39] and I84A (PDB: 2G4E) [39] TTR variants at neutral pH are very similar to that of the wild-type protein In both cases, the amino acid replacements are not associated with significant local conformational changes Ile84 occupies a central posi-tion in a hydrophobic patch of TTR involved in hydro-phobic interactions with RBP; its replacement by a serine can perturb the polarity of the microenvironment

at the interface, thereby impairing protein–protein rec-ognition A reduction of the steric hindrance of the side chain of Ile84 as a consequence of the I84A mutation can instead perturb the interaction It is concluded that the residue at position 84 is particularly relevant for protein–protein recognition In this respect, it should

be noted that, as in the case of Val20 and Arg21, two lle84 residues of two subunits present in two different dimers of the TTR tetramer are involved at the same time in the interactions with one RBP molecule (Table 1) Therefore, an amino acid substitution at position 84 in TTR can lead to the loss of two relevant contacts between two residues of an RBP molecule and both dimers of the TTR counterpart Moreover, we have demonstrated that, at variance with wild-type TTR, at pH 4.6, both I84S and I84A mutations induce

a remarkable conformational change in the region com-prising residue 84, with the disruption of the a-helix itself [39] It is tempting to speculate that the two amino acid replacements cause a destabilization of the TTR region hosting the mutation, as revealed by the structural alteration at acidic pH, which in turn may affect the interaction with RBP

S85A TTR variant Ser85 appears to be relevant for the TTR–RBP inter-action on the basis of the structure of the complex because it participates in several contacts with RBP residues: two are H-bond interactions, one between the Ser85 -OH group and the amide nitrogen of Lys99 of RBP and the other between the amide nitrogen of

Table 1 Contacts between amino acid residues in the RBP–TTR–

Fab complex characterized by interatomic distances within 4.0 A ˚ :

interactions between RBP and TTR Interactions were analyzed

using the program CONTACT of the CCP4 package [54].

RBP chain E TTR chain A TTR chain B TTR chain C

a

Denotes the participation of TTR residues in at least one polar

contact b An H-bond distance is present between at least two

atoms of interacting residues of RBP and TTR.

Table 2 Contacts between amino acid residues in the RBP–TTR–

Fab complex characterized by interatomic distances within 4.0 A ˚ :

interactions between RBP and Fab Interactions were analyzed

using the program CONTACT of the CCP4 package [54].

a An H-bond distance is present between at least two atoms of

interacting residues of RBP and Fab.bDenotes the participation of

Fab residues in at least one polar contact.

Trang 6

Ser85 and the carbonyl oxygen of Phe96 of RBP

(Table 1) Although the latter can be preserved in the

S85A variant, the former is lost, possibly contributing

to an approximately five-fold decrease in binding affin-ity caused by the mutation (Table 3) It can be specu-lated that the loss of interactions caused by the

A

B

Fig 2 Multiple sequence alignments for RBP (A) and TTR (B) from different vertebrate species The residues that are identical in all the sequences considered for each alignment are shaded in red; the residues that are identical or chemically similar in at least five sequences for each alignment are denoted by red characters (similarity groups are: HKR, DE, STNQ, AVLIM, FYW, PG, C) The amino acid residues in the human TTR and RBP sequences more directly involved in RBP–TTR interactions (Table 1) are denoted by arrowheads Numbering and secondary structure elements are based on the structures of human RBP (PDB: 1JYD) and TTR (PDB: 1F41) GenBank or SwissProt acces-sion numbers are: human TTR, PO2766; rat TTR, NP_036813; chicken TTR, CAA43000; zebrafish TTR, AAH81488; sea bream TTR, AF059193; trout TTR, CB497711 (EST sequence); human RBP, P02753; rat RBP, NM_013162; chicken RBP, P41263; zebrafish RBP, EF373650; sea bream RBP, AAF79021; trout RBP, P24774 Sequences containing the signal peptide have been reported when the N-termini

of the mature proteins are not known Sequence alignments were constructed by CLUSTALW [58] and rendered with ESPRIPT [59].

Trang 7

mutation may be partially compensated by a novel

hydrophobic interaction in a hydrophobic patch

involving Ala85

D99A and S100E TTR variants These are important mutations because each of them causes an approximately 20-fold decrease in binding affinity of TTR for RBP (Table 3 and Fig 3A) Both replaced residues interact with Lys99 of RBP and, moreover, Ser100 is close to Trp91 (Table 1) Conse-quently, it is conceivable that the replacements of Asp99 by a hydrophobic residue and of Ser100 by a charged residue significantly perturb the interactions However, it is likely that the effects of the D99A and S100E mutations are less drastic compared to the I84S and V20S replacements because the interactions involv-ing residues at positions 99 and 100 are present at the periphery of a contact area between RBP and TTR Moreover, the new electrostatic situation for the TTR variants could result in new interactions of the mutated residues with the solvent

Y114F and Y114H TTR variants

A special case is represented by Tyr114: its substitution for a phenylalanine lowers the dissociation constant of the protein–protein complex by an approximate factor

of two, whereas the dissociation constant is three-fold higher when Tyr114 is replaced by a histidine (Table 3 and Fig 3A) We have also determined the crystal structure of the amyloidogenic Y114H variant: no sig-nificant conformational changes have been observed, and, in particular, the side chain of His114 maintains the same position and orientation compared to Tyr114 The same holds for the position and orienta-tion of the Phe114 residue present in the structure of both chicken TTR [26], which interacts well with RBP [17,40], and piscine TTR [27] The -OH group of Tyr114 forms an H-bond with the -OH group of Ser95

of RBP Moreover, Tyr114 is in a hydrophobic patch

of TTR, despite its proximity to the protein surface Its replacement by a phenylalanine is not drastic in terms of modification of the surface potential but it leads to the loss of an H-bond interaction It must be assumed that the loss of a H-bond interaction for the Y114F variant is compensated by some conforma-tional rearrangements that result in stronger

hydro-A

B

Fig 3 Human TTR mutations affecting TTR–RBP interactions.

(A) Typical fluorescence anisotropy titrations of human holoRBP

(3 l M ) with human TTR: wild-type, black; V20S TTR, gray; I84S

TTR, red; D99A TTR, green; Y114H TTR, blue; Y114F TTR, orange.

Fluorescence anisotropy values are plotted as a function of human

TTR molar concentration Lines represent theoretical binding curves

(for details, see Experimental procedures) corresponding to

dissoci-ation constants of 0.34 l M for wild-type TTR, 5.99 l M for D99A

TTR, 1.04 l M for Y114H TTR and 0.17 l M for Y114F TTR (B)

Ste-reo view showing the superposition of the Ca chain traces of

wild-type TTR (PDB: 1F41, red) and the V20S TTR variant (green) in the

area around residue 20 The side chains of residues Ser20 or Val20

and Arg21 are shown.

Table 3 Dissociation constants of complexes between human holoRBP and human TTR variants as determined by means of fluorescence anisotropy titrations Data represent the average of at least three independent measurements.

TTR Wild-type V20S a V30M a,b L55P a,b L58H b T60A a,b I84S a,b,c I84A a S85A D99A c S100E c Y114H a,b Y114F c

a The structure for the TTR variant is available: V20S and Y114H [present study]; V30M [55]; L55P, [56]; T60A, [57]; I84S and I84A, [39].

b Amyloidogenic TTR variant c Position affected by significant amino acid replacements in piscine TTR compared to human TTR (Fig 2B).

d Almost negligible interaction e Lack of interaction.

Trang 8

phobic interactions, possibly explaining the higher

affinity between RBP and this TTR variant The

replacement of Tyr114 by a potentially charged

histi-dine could have a marked effect on the surface

poten-tial; the finding that the Y114H mutation does not

drastically impair the RBP–TTR interaction suggests

that His114 is not protonated in the protein–protein

complex

Modeling of the interactions of piscine TTR and

RBP with protein counterparts within the

TTR–RBP–Fab complex

The observation that human TTR and RBP are bound

in the TTR–RBP–Fab complex without undergoing

sig-nificant conformational changes compared to the

un-complexed proteins prompted us to assess the ability of

the two proteins from fish, which are unable to interact

with each other [27], to fit within the structure of the

TTR–RBP–Fab complex by replacing the

correspond-ing human proteins present in the complex The

struc-ture of sea bream (Sparus aurata) TTR is known [27],

whereas no structure for a fish RBP is available to date

Therefore, only a theoretical model for the structure of

sea bream RBP could be obtained with the

Swiss-Model server [41] The structure of sea bream TTR was

superimposed on that of human TTR present in the

TTR–RBP–Fab complex, giving rise to a hypothetical

model of the mixed piscine TTR–human RBP complex

(Fig 4) The most relevant difference can be observed

for loop 98–102 of all the subunits of TTR, especially

for subunits A and C, due to some remarkable

muta-tions affecting interacting residues (Table 3 and

Fig 2B) The conformation of loop 80–85 of piscine

TTR also changes slightly (Fig 4), possibly due to

relevant mutations in this area (Table 3 and Fig 2B)

The same holds for a model in which the human RBP

structure is also replaced by a theoretical sea bream RBP structure, giving rise to a hypothetical piscine RBP–TTR complex (Fig 4) Conformational differ-ences for TTR along with point mutations that have no effect on TTR structure (Fig 2B) may account for the experimentally determined lack of binding affinity between piscine TTR and RBP, as well as between piscine TTR and human RBP [27] Only limited confor-mational differences between piscine and human RBP are found Accordingly, the degree of conservation of the putative interacting residues is remarkably higher in piscine RBP than in piscine TTR; the only significant amino acid difference in piscine RBP compared to human RBP is K99T (Fig 2A) These features may explain the existence of an affinity, albeit weak, between piscine RBP and human TTR [27,42]

Discussion

The human holoRBP–TTR complex is relatively weak, being characterized by a dissociation constant of approximately 0.35 lm (Table 3) It has been suggested that this feature may be correlated with the need for the presence in plasma of a small but significant amount of uncomplexed holoRBP, which can thus leave the circulation more easily to deliver the retinol

to the target tissues [7] A limited number of residues and retinol itself are mainly responsible for the rela-tively weak RBP–TTR interaction An important role played by the retinol hydroxyl end group in the interaction is consistent with the low binding affinity

of apoRBP compared to that of holoRBP for TTR [16,17] and with the drastic interference with the interaction between the two proteins by RBP-bound fenretinide, a retinoid that bears a bulky end group in place of the retinol hydroxyl group [43,44] Moreover, the conformational change affecting one of the loops

Fig 4 Modeling of piscine TTR and RBP within the TTR–RBP–Fab complex Stereo view showing interacting regions between RBP (magenta) and TTR (orange) in the human RBP–TTR complex bound to Fab, with a superimposed model of the piscine RBP–TTR complex (green) based on the structure of sea bream TTR (PDB: 1OO2) and on a hypothetical model of the piscine RBP structure The two regions of TTR that differ significantly in the structures (98–102 and 80–85) are labeled.

Trang 9

surrounding the opening of the b-barrel (in particular,

residues Leu35 and Phe36) in apo-RBP compared to

holoRBP [30,31] is likely to contribute to the

weaken-ing of the interaction of apoRBP with TTR due to the

involvement of such a loop in RBP–TTR recognition

Despite a few exceptions, the substitutions of

hydro-philic for hydrophobic side chains in TTR contact

regions generally have a rather pronounced

dissociat-ing effect on the RBP–TTR complex, consistent with

the important role played by interfacial apolar

inter-actions In general, the changes in the TTR molecule

induced by amyloidogenic mutations do not interfere

with the interactions between RBP and TTR, unless

the mutations are located in contact areas The

amyloi-dogenic mutations V30M, L55P, L58H and T60A have

a limited effect on the binding affinity between RBP

and TTR (Table 3), in accordance with the lack of the

replaced residues in contact areas; moreover, it can be

inferred that such amyloidogenic mutations do not

cause large conformational changes in the TTR

mole-cule that might affect indirectly the RBP–TTR

recogni-tion Conversely, the amyloidogenic I84S mutation,

which affects a residue that is crucial for

protein–pro-tein interactions, causes the lack of recognition

between RBP and TTR and an altered plasma

trans-port of RBP by TTR [37,38] It might be hypothesized

that the ability of RBP to interact well with relevant

amyloidogenic TTR variants, such as V30M, L55P,

L58H and T60A, can protect them from amyloid

aggregation However, it should be noted that the

plasma concentration of TTR is significantly higher

than that of RBP [7], so that a protective effect of

RBP on TTR can only be limited

Despite the high symmetry of TTR, which is a

homo-tetramer with virtually four identical binding sites for

RBP, a 1 : 1 TTR : RBP complex is believed to be

present in plasma due to the excess of TTR over RBP

[7] Binding data obtained in solution [17,37,45] and

structural data [35,36] have shown that a maximum of

two RBP molecules can be bound by one TTR

tetra-mer The binding of two RBP molecules to an

uncom-plexed TTR tetramer partially hinders the potential

binding of two nearby RBP molecules, thereby limiting

the possible interactions with tetrameric TTR to two

RBP molecules [35,36] However, two distinct

macro-molecular organizations, both accounting for the 1 : 2

TTR : RBP stoichiometry, have been described for

the heterologous and the homologous RBP–TTR

complexes [35,36] The crystal structure of the TTR

tetramer is characterized by 222 symmetry One of the

three orthogonal two-fold axes runs through the

central channel harboring the two thyroid hormone

binding sites In the heterologous chicken RBP–human

TTR complex, the two TTR-bound RBP molecules are related by one of the two available two-fold axes that are perpendicular to the central channel of TTR [35] Instead, in the homologous human RBP–human TTR complex, as well as in the case of our structure of the TTR–RBP–Fab complex, the two TTR-bound RBP molecules are related by the two-fold axis running through the central channel of TTR [36] (Fig 1A) Because the two situations are chemically equivalent, a possible explanation for the observed different assem-bly is that, in solution, both modes of assemassem-bly can be present and that the crystallization process selects one

of them according to the best packing

By comparing the structure of the human TTR– human RBP complex bound to Fab with those of the heterologous human TTR–chicken RBP complex [35] and of the homologous human TTR–human RBP complex [36], a good correspondence between these structures with regard to interacting surfaces of TTR and RBP has been found In the case of the human TTR–human RBP complex, however, it should be noted that one of the two TTR-bound RBP molecules has been reported to participate in the interaction with the last C-terminal amino acid residues (especially Leu182 and Leu183), thereby generating an asymmetry within the complex [36] At variance with this observa-tion, our TTR–RBP–Fab structure does not reveal the presence of interactions between the carboxy terminus

of RBP and TTR On the other hand, it should be noted that chicken RBP, in which eight C-terminal res-idues are missing compared to human RBP (Fig 2A), binds to human TTR with an affinity similar to that exhibited by human RBP [40; C Folli and R Berni, unpublished data], which suggests that the carboxy terminus of human RBP is not so crucial for the inter-action with TTR

The RBP–TTR complex is normally isolated from the serum of terrestrial vertebrates, such as mammals and birds [7] Moreover, purified human and chicken RBP and TTR have been found to cross-interact [40]

By contrast, RBP could be isolated from the serum of different fish species only as uncomplexed protein [27,42,46], suggesting that, in fish, it is present in the circulation as an uncomplexed protein without affinity for TTR In accordance with this observation, the lack

of binding affinity between purified piscine RBP and TTR has been established [27] The comparison of the amino acid sequences of piscine RBPs and TTRs with those of the same proteins from terrestrial vertebrates reveals the presence of remarkable differences in regions involved in protein–protein interactions for TTR, whereas only limited differences are present in the case of RBP (Fig 2A,B) In particular, the amino

Trang 10

acid replacements at positions 82, 84, 99 and 100 in

piscine TTR compared to the human and chicken

pro-teins are drastic and are present at positions critical

for the interaction between RBP and TTR (Table 1

and Fig 2B), and some of them (I84S, D99A and

S100E) are shown in the present study to impair or

abolish protein–protein recognition (Table 3 and

Fig 3A) The results obtained are consistent with the

notion that evolutionary changes affecting a limited

number of surface-exposed residues led to the

appear-ance in terrestrial vertebrates of the TTR function of

cotransport of retinol through the interaction with

holoRBP in plasma, in addition to that of the

distribu-tion of thyroid hormones in the extracellular fluids

Experimental procedures

Materials

HoloRBP was purified from human plasma as reported

previously [17] Recombinant wild-type human TTR and

TTR variants I84S and I84A were prepared and quantified

as described previously [39] All chemicals were of analytical

grade

Site-directed mutagenesis, bacterial expression

and purification of human TTR variants

The recombinant human TTR variants V20S, L55P, L58H,

T60A, S85A, D99A, S100E, Y114F and Y114H were

pre-pared by PCR using the plasmid pET11b-human TTR [39]

as template, a high-fidelity thermostable DNA polymerase

(Pfu Ultra II Fusion HS DNA polymerase; Stratagene, La

Jolla, CA, USA) and mutagenic primers complementary to

opposite strands For each mutation, the product of

reac-tion was treated with DpnI (New England Biolabs, Beverly,

MA, USA) to digest the parental DNA template This

pro-cedure allowed us to select the newly synthesized and

potentially mutated plasmids The products of each

diges-tion were used to transform Escherichia coli XL1 Blue cells

Single clones were then sequenced to confirm the

occur-rence of the desired mutation Finally, mutant plasmids

were electroporated into E coli BL21 (DE3) cells The

expression of TTR variants was induced by 1 mm isopropyl

cells were disrupted by sonication TTR variants were

puri-fied as described for wild-type TTR [39]

Determination of the amino acid sequences of

anti-RBP Fab variable domains

Total RNA obtained from the cell line producing the

anti-RBP murine monoclonal antibody A8P3 [47] was subjected

to retrotranscription into cDNA employing the Superscript

Preamplification System (Gibco, Gaithersburg, MD, USA) The cDNA sequences encoding for the variable domains of the H and L chains of the monoclonal antibody A8P3 were PCR amplified using a mixture of 18 5¢ primer VKBACK mix and a mixture of five 3¢ primer VKFOR for the VK gene and 20 5¢ primer VHBACK mix and a mixture of five 3¢ primer VHFOR mix for the VH gene [48] Each domain was cloned using the TA cloning kit (Invitrogen, Carlsbad,

CA, USA) and sequenced using an automated model 377 sequenator (Applied Biosystems, Foster City, CA, USA) The amino acid sequences of the variable domains of L and

H chains of the antibody A8P3 are provided in Fig S1

Binding assay for the interaction between holoRBP and TTR variants

To study the in vitro interaction of holoRBP with TTR variants, the highly fluorescent RBP-bound retinol provides

an intense signal which is suitable for fluorescence polariza-tion measurements [40] The intensities of the vertical (I ||) and horizontal (I^) components of the fluorescence of RBP-bound retinol (excitation at 330 nm and emission at

460 nm) were recorded at an angle of 90 to the vertically polarized excitation beam A correction factor, G, equal to

perpendicular direction) was used to correct for the unequal transmission of differently polarized light Fluorescence anisotropy (A) was determined according to the equation:

3.0 lm) in 0.05 m sodium phosphate (pH 7.2) and 0.15 m

concen-trated solutions of human TTR (wild-type or mutant forms) to the RBP-containing cuvette and the increase in fluorescence anisotropy of the RBP-bound retinol upon complex formation was monitored The fraction of RBP bound by TTR (a) was calculated for every point of the

value of RBP-bound retinol for a certain molar

anisotropy values (i.e in the presence of an excess saturat-ing TTR and in the absence of TTR, respectively) Bindsaturat-ing data were analyzed as described [12] Fluorescence anisot-ropy measurements were carried out with a LS-50B spectro-fluorometer (Perkin-Elmer, Waltham, MA, USA)

Crystallization, data collection, structure determination and refinement for the TTR–RBP–Fab complex and the V20S and Y114 TTR variants

Crystallization and preliminary X-ray data for the macro-molecular complex formed by human transthyretin, human holoRBP and a murine anti-RBP Fab have been reported

Ngày đăng: 30/03/2014, 02:20

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm